Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015
Cash flows from operating activities:
Net earnings	$ 699,058	$ 424,981
Adjustments to reconcile net earnings to net cash provided by operating activities:
Restructuring	28,300	18,716
Tradename impairment	47,905	0
Depreciation and amortization	305,088	268,622
Deferred income taxes	(27,887)	(35,171)
(Gain) loss on disposal of property, plant and equipment	(10,849)	349
Stock-based compensation expense	28,841	24,488
Changes in operating assets and liabilities, net of effects of acquisitions:
Receivables, net	(255,311)	(140,475)
Inventories	(53,578)	(3,219)
Other assets and prepaid expenses	67,375	(33,612)
Accounts payable and accrued expenses	166,492	146,025
Other liabilities	(10,753)	(13,752)
Net cash provided by operating activities	984,681	656,952
Cash flows from investing activities:
Additions to property, plant and equipment	(460,760)	(352,070)
Acquisitions, net of cash acquired	0	(1,211,715)
Net cash used in investing activities	(460,760)	(1,563,785)
Cash flows from financing activities:
Payments on Senior Credit Facilities	(467,618)	(1,087,338)
Proceeds from Senior Credit Facilities	386,551	1,057,661
Payments on Commercial Paper	(17,614,864)	(13,456,251)
Proceeds from Commercial Paper	17,835,126	13,856,454
Repayment of senior notes	(645,555)	0
Proceeds from 2.00% Senior Notes	0	564,653
Payments of acquired debt and other financings	0	(9,321)
Debt issuance costs	(1,086)	(6,859)
Change in outstanding checks in excess of cash	(1,924)	1,709
Proceeds and net tax benefit from stock transactions	8,149	9,798
Net cash (used in) provided by financing activities	(501,221)	930,506
Effect of exchange rate changes on cash and cash equivalents	7,716	(10,834)
Net change in cash and cash equivalents	30,416	12,839
Cash and cash equivalents, beginning of period	81,692	97,877
Cash and cash equivalents, end of period	$ 112,108	$ 110,716